New Licensing Rules for High-Alcohol Drug Formulations

What changed in India's alcohol-formulation licensing rules?

India's Ministry of Health and Family Welfare has amended the Drugs Rules, 1945, to remove a licensing exemption that previously covered many high-alcohol medicinal formulations. Products containing more than 12% v/v ethyl alcohol, in quantities over 30 mL, must now be licensed under the Drugs and Cosmetics Act, 1940, and can only be sold against a doctor's prescription.

The amendment was announced in July 2026 and shifts these products from the exempted Schedule K category into Schedule H1 — the same regulatory category used for many antibiotics and other medicines the government wants to track more closely because of misuse risk.

Which products does this actually cover?

The rule targets a specific and somewhat overlooked category: aromatic tinctures and similar preparations that are technically medicines but have historically been treated as low-risk household items. The Ministry specifically named tinctures of cardamom, ginger, and other aromatic preparations as examples.

What made these products a regulatory blind spot is their alcohol content. Some of these formulations contain ethyl alcohol concentrations as high as 80–90% v/v — comparable to, or higher than, many spirits — while being sold with minimal oversight because they were classified as low-risk medicinal products decades ago.

Why the government made this change

The Ministry's stated reason is straightforward: preventing misuse. High-alcohol tinctures that could be bought without a prescription created an avenue for people to obtain concentrated alcohol for intoxication rather than for the aromatic or digestive purposes the products were originally formulated for.

According to the government's own notification, the change followed references received from state governments flagging concerns about this kind of misuse. Rather than banning the products outright — which would cut off access for people who use them for genuine medical reasons — the Ministry chose to route them through the same controlled pharmaceutical supply chain used for other prescription-only drugs.

What Schedule H1 status actually means

Schedule H1 is a specific regulatory category under India's Drugs Rules for medicines that need tighter control than an ordinary prescription drug, but don't need to be as tightly restricted as narcotics. Medicines in this category can only be sold against a prescription from a Registered Medical Practitioner, and pharmacies are required to keep detailed sale records — including the patient's name and address, the prescriber's details, and the quantity dispensed.

This record-keeping requirement is what gives Schedule H1 its regulatory teeth. It creates a paper trail that lets drug authorities trace where a batch of a high-alcohol formulation went, rather than treating it as an anonymous over-the-counter purchase.

What this means if you use one of these products

If you or a family member regularly uses a high-alcohol tincture — for a digestive complaint, as an aromatic preparation, or for another legitimate reason — the practical change is that you'll now need a prescription to buy it, and your pharmacist may ask for more information than before at the point of sale.

This isn't a sign the product itself has become more dangerous or that its formulation has changed. It reflects a shift in how tightly the government wants to track who buys it and why. If a product you've used for years is suddenly unavailable off the shelf, ask your pharmacist whether it now falls under the new Schedule H1 requirement, and speak with your doctor about getting a prescription if you have an ongoing medical need for it.

How this fits into broader drug regulation efforts

This amendment isn't happening in isolation. The Ministry of Health and Family Welfare has been actively revising the Drugs Rules, 1945, on multiple fronts in 2026 — including, separately, a move to simplify the process for importing drugs for research, testing, or analysis (commonly referred to as Form 11 clearance), aimed at improving ease of doing business in the pharmaceutical sector.

Taken together, these moves suggest a regulator trying to balance two goals at once: tightening control where there's a documented misuse risk, while easing procedural friction elsewhere in the system. The high-alcohol formulation rule falls squarely into the first category.

A history of alcohol-based products slipping through regulatory gaps

This isn't the first time alcohol-containing products have created regulatory ambiguity in India. During the COVID-19 pandemic, alcohol-based hand sanitizers and hand rubs went through a similar period of uncertainty, as manufacturers scrambled to scale up production while regulators debated whether these products should be treated as drugs, cosmetics, or disinfectants — each classification carrying different licensing rules.

That episode showed how quickly gaps in classification can appear when demand for an alcohol-containing product spikes faster than the regulatory framework anticipated. The current tightening of rules around high-alcohol tinctures reflects a similar underlying concern, just approached from the opposite direction: closing a loophole that had existed quietly for years rather than reacting to a sudden surge in demand. In both cases, the common thread is that products sitting at the boundary between "medicine," "cosmetic," and "consumable" tend to attract regulatory attention once their alcohol content becomes a misuse concern.

What manufacturers and pharmacies need to do

For manufacturers of affected formulations, the shift means applying for the appropriate license under the Drugs and Cosmetics Act if they haven't already, and adjusting packaging and labelling to reflect Schedule H1 status. For pharmacies, it means updating point-of-sale practices — checking for a valid prescription before dispensing, and maintaining the patient and prescriber records the schedule requires.

Retailers who previously stocked these tinctures as general over-the-counter items will need to either obtain a drug license to continue selling them or stop stocking the affected products altogether. Given how routinely some of these tinctures have been sold in general stores rather than licensed pharmacies, the transition period is likely to see some genuine confusion at the retail level before enforcement catches up with the new rule.

FAQ

What is the new rule on high-alcohol medicinal formulations in India? The Ministry of Health and Family Welfare removed a licensing exemption for medicinal products containing more than 12% v/v ethyl alcohol in packs over 30 mL. These products now require a drug license and have moved to prescription-only Schedule H1.

Which products are affected by this change? The rule primarily affects aromatic tinctures such as those of cardamom and ginger, and similar preparations that can contain ethyl alcohol concentrations as high as 80–90% v/v, some of which were previously sold without a prescription.

Why did the government tighten these rules? The government said some of these high-alcohol formulations were being misused for intoxication rather than their intended medicinal purpose, and it received concerns from state governments about this misuse before making the change.

Do I now need a prescription to buy these products? Yes. Once a product falls under the new rule, it can only be sold against a prescription from a Registered Medical Practitioner, and the pharmacy is required to keep detailed records of the sale.

Does this mean these products are more dangerous than before? No, the formulations themselves haven't changed. The rule change is about regulatory oversight and misuse prevention, not a new safety finding about the products.

Takeaway

If a tincture or aromatic preparation you've bought over the counter for years suddenly requires a prescription, it's likely caught up in this rule change rather than a supply issue at your local pharmacy. Ask your pharmacist directly, and if you have a genuine ongoing need, a quick conversation with your doctor should keep your access uninterrupted.

5. Sources

• Ministry of Health and Family Welfare, Government of India — amendment to the Drugs Rules, 1945 (July 2026)

• ANI — "Centre amends drugs rules to strengthen regulation of high alcohol-containing drug formulations" (July 10, 2026)

• The Tribune — "High-alcohol medicinal formulations to require licence, prescription"

• Medical Dialogues — "High-Alcohol Medicines to Require Prescription and Licence"